01/06/2023 3:16 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2022 3:42 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2022 7:05 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/16/2022 4:43 PM | Atara Biotherapeutics (Issuer) Banard Charlene A. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/18/2022 7:13 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2022 7:13 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
11/18/2022 7:13 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2022 7:13 PM | Atara Biotherapeutics (Issuer) Dupont Jakob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2022 3:20 PM | Atara Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/28/2022 3:30 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2022 3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/18/2022 5:20 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2022 5:21 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2022 5:21 PM | Atara Biotherapeutics (Issuer) Dupont Jakob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/18/2022 5:24 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2022 3:14 PM | Atara Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/22/2022 3:06 PM | Atara Biotherapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/29/2022 3:48 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2022 3:48 PM | Atara Biotherapeutics (Issuer) SEIDENBERG BETH C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2022 3:48 PM | Atara Biotherapeutics (Issuer) Renaud Ronald C JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2022 3:48 PM | Atara Biotherapeutics (Issuer) DOBMEIER ERIC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2022 3:48 PM | Atara Biotherapeutics (Issuer) Baynes Roy D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2022 3:48 PM | Atara Biotherapeutics (Issuer) Roncarolo Maria Grazia (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2022 3:48 PM | Atara Biotherapeutics (Issuer) MALLIK AMEET (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2022 3:48 PM | Atara Biotherapeutics (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2022 3:48 PM | Atara Biotherapeutics (Issuer) HEIDEN WILLIAM K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/27/2022 3:48 PM | Atara Biotherapeutics (Issuer) Gallagher Carol Giltner (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2022 3:02 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/19/2022 4:16 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2022 4:20 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2022 4:04 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2022 4:08 PM | Atara Biotherapeutics (Issuer) Dupont Jakob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/05/2022 3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2021 6:32 PM | Atara Biotherapeutics (Issuer) Dupont Jakob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2021 6:34 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2021 6:35 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2021 6:36 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2021 6:37 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2021 3:02 PM | Atara Biotherapeutics (Issuer) Yarema Kristin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2021 6:09 PM | Atara Biotherapeutics (Issuer) Gallagher Carol Giltner (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/09/2021 6:11 PM | Atara Biotherapeutics (Issuer) Roncarolo Maria Grazia (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2021 6:13 PM | Atara Biotherapeutics (Issuer) Renaud Ronald C JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2021 6:14 PM | Atara Biotherapeutics (Issuer) HEIDEN WILLIAM K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2021 6:16 PM | Atara Biotherapeutics (Issuer) SEIDENBERG BETH C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2021 6:03 PM | Atara Biotherapeutics (Issuer) Baynes Roy D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2021 6:05 PM | Atara Biotherapeutics (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2021 6:07 PM | Atara Biotherapeutics (Issuer) DOBMEIER ERIC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2021 3:06 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2021 3:29 PM | Atara Biotherapeutics (Issuer) Yarema Kristin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2021 3:30 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2021 3:31 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2021 3:32 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2021 3:32 PM | Atara Biotherapeutics (Issuer) Dupont Jakob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2021 3:33 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2021 5:32 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/07/2021 3:36 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/30/2021 4:18 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/30/2021 4:19 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2021 6:25 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 4:13 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 4:14 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 4:15 PM | Atara Biotherapeutics (Issuer) Yarema Kristin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 4:15 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 4:16 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/03/2021 4:17 PM | Atara Biotherapeutics (Issuer) Dupont Jakob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2021 4:05 PM | Atara Biotherapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/09/2021 6:59 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2021 6:59 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2021 3:02 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2021 6:31 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/18/2020 5:35 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/09/2020 4:08 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/07/2020 7:26 AM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/18/2020 3:07 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2020 3:07 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2020 3:08 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/16/2020 3:19 PM | Atara Biotherapeutics (Issuer) Atara Biotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/09/2020 3:41 PM | Atara Biotherapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/09/2020 3:11 PM | Atara Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/09/2020 3:05 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2020 6:37 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2020 6:38 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/20/2020 6:39 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2020 3:18 PM | Atara Biotherapeutics (Issuer) Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 8:15 PM | Atara Biotherapeutics (Issuer) SEIDENBERG BETH C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 4:43 PM | Atara Biotherapeutics (Issuer) Baynes Roy D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 4:44 PM | Atara Biotherapeutics (Issuer) DOBMEIER ERIC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 4:45 PM | Atara Biotherapeutics (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 4:46 PM | Atara Biotherapeutics (Issuer) Gallagher Carol Giltner (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/17/2020 4:46 PM | Atara Biotherapeutics (Issuer) HEIDEN WILLIAM K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/20/2020 5:10 PM | Atara Biotherapeutics (Issuer) Touchon Pascal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 5:11 PM | Atara Biotherapeutics (Issuer) Koppikar Utpal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2020 5:11 PM | Atara Biotherapeutics (Issuer) Newell Joe (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/19/2020 6:16 PM | Atara Biotherapeutics (Issuer) Dupont Jakob (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/19/2020 6:17 PM | Atara Biotherapeutics (Issuer) Dupont Jakob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2020 6:43 PM | Atara Biotherapeutics (Issuer) Renaud Ronald C JR (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/30/2020 6:44 PM | Atara Biotherapeutics (Issuer) Renaud Ronald C JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2020 4:25 PM | Atara Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/21/2020 3:16 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/21/2020 3:17 PM | Atara Biotherapeutics (Issuer) Murugan Amar (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |